Andreas Müller1, Alina Jurcoane1, Burkhard Mädler2, Philip Ditter1, Hans Schild1, Elke Hattingen3. 1. Neuroradiology, Department of Radiology, University Hospital Bonn, Sigmund Freud Str. 25, 53127, Bonn, Germany. 2. UB Healthcare, Philips GmbH, Lübeckertordamm 5, 20099, Hamburg, Germany. 3. Neuroradiology, Department of Radiology, University Hospital Bonn, Sigmund Freud Str. 25, 53127, Bonn, Germany. elke.hattingen@ukb.uni-bonn.de.
Abstract
PURPOSE: To assess if ratios of T1-weighted (T1w) signal intensity (SI) and quantitative T1 relaxometry (qT1) change on serial administration of macrocyclic gadobutrol. METHODS: A total of 17 glioblastoma patients were scanned at 3.0 T magnetic resonance imaging (MRI) every 6 weeks after tumor resection with standard MRI and T1 and T2 relaxometry before and after gadobutrol administration. On co-registered images T1w SI was measured and relaxation times T1 (qT1) and quantitative T2 (qT2) were quantified in several deep grey matter nuclei as ratios relative to frontal white matter and to the pons. Ratio changes were evaluated over time with a paired t‑test and multiple regression. RESULTS: An average of 8 (range 5-14) scans per patient were completed. Ratios of T1w SI, qT1 and qT2 remained unchanged for all target regions from the first to the last time point (p > 0.05) and did not correlate with the number of gadobutrol administrations. Multivariate regression showed no significant impact of gadobutrol on qT1 or qT2 ratios, but a significant negative effect on T1w SI ratios. Gender also had no impact on the ratios but age had a significant negative influence on the qT1 ratio. CONCLUSION: Multiple administrations of a macrocyclic contrast agent did not change relaxation time T1 ratios in any deep grey matter structure.
PURPOSE: To assess if ratios of T1-weighted (T1w) signal intensity (SI) and quantitative T1 relaxometry (qT1) change on serial administration of macrocyclic gadobutrol. METHODS: A total of 17 glioblastomapatients were scanned at 3.0 T magnetic resonance imaging (MRI) every 6 weeks after tumor resection with standard MRI and T1 and T2 relaxometry before and after gadobutrol administration. On co-registered images T1w SI was measured and relaxation times T1 (qT1) and quantitative T2 (qT2) were quantified in several deep grey matter nuclei as ratios relative to frontal white matter and to the pons. Ratio changes were evaluated over time with a paired t‑test and multiple regression. RESULTS: An average of 8 (range 5-14) scans per patient were completed. Ratios of T1w SI, qT1 and qT2 remained unchanged for all target regions from the first to the last time point (p > 0.05) and did not correlate with the number of gadobutrol administrations. Multivariate regression showed no significant impact of gadobutrol on qT1 or qT2 ratios, but a significant negative effect on T1w SI ratios. Gender also had no impact on the ratios but age had a significant negative influence on the qT1 ratio. CONCLUSION: Multiple administrations of a macrocyclic contrast agent did not change relaxation time T1 ratios in any deep grey matter structure.
Authors: Alexander Radbruch; Lukas D Weberling; Pascal J Kieslich; Oliver Eidel; Sina Burth; Philipp Kickingereder; Sabine Heiland; Wolfgang Wick; Heinz-Peter Schlemmer; Martin Bendszus Journal: Radiology Date: 2015-04-06 Impact factor: 11.105
Authors: Alexander Radbruch; Robert Haase; Pascal J Kieslich; Lukas D Weberling; Philipp Kickingereder; Wolfgang Wick; Heinz-Peter Schlemmer; Martin Bendszus Journal: Radiology Date: 2016-12-07 Impact factor: 11.105
Authors: René-Maxime Gracien; Lucas Nürnberger; Pavel Hok; Stephanie-Michelle Hof; Sarah C Reitz; Udo Rüb; Helmuth Steinmetz; Rüdiger Hilker-Roggendorf; Johannes C Klein; Ralf Deichmann; Simon Baudrexel Journal: Eur Radiol Date: 2016-07-05 Impact factor: 5.315
Authors: Alexander Radbruch; Robert Haase; Philipp Kickingereder; Philipp Bäumer; Sebastian Bickelhaupt; Daniel Paech; Wolfgang Wick; Heinz-Peter Schlemmer; Angelika Seitz; Martin Bendszus Journal: Radiology Date: 2017-03-08 Impact factor: 11.105
Authors: Nozomu Murata; Luis F Gonzalez-Cuyar; Kiyoko Murata; Corinne Fligner; Russell Dills; Daniel Hippe; Kenneth R Maravilla Journal: Invest Radiol Date: 2016-07 Impact factor: 6.016
Authors: Andreas Müller; Alina Jurcoane; Sied Kebir; Philip Ditter; Felix Schrader; Ulrich Herrlinger; Theophilos Tzaridis; Burkhard Mädler; Hans H Schild; Martin Glas; Elke Hattingen Journal: Cancer Med Date: 2016-11-28 Impact factor: 4.452
Authors: Charles L Bennett; Zaina P Qureshi; A Oliver Sartor; Leann B Norris; Alanna Murday; Sudha Xirasagar; Henrik S Thomsen Journal: Clin Kidney J Date: 2012-02
Authors: Carlo C Quattrocchi; Joana Ramalho; Aart J van der Molen; Àlex Rovira; Alexander Radbruch Journal: Eur Radiol Date: 2018-11-09 Impact factor: 5.315
Authors: Peter Kelemen; Jamila Alaoui; Dominik Sieron; Andrew Chan; Christian P Kamm; Mirjam R Heldner; Jan Gralla; Roland Wiest; Rajeev K Verma Journal: Sci Rep Date: 2018-11-15 Impact factor: 4.379